Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.

Autor: Farge D; Unité de Médecine Interne (UF04): CRMR MATHEC, Maladies Auto-immunes et Thérapie Cellulaire, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Nord-Université de Paris, Paris, France; Faculté de Médecine, Institut de Recherche St-Louis, EA-3518, Université de Paris, Paris, France; Department of Medicine, Research Institute of the McGill University Health Centre, McGill University, Montreal, QC, Canada. Electronic address: itaccme@gmail.com., Frere C; INSERM UMRS 1166, GRC 27 GRECO, DMU BioGeM, Assistance Publique Hôpitaux de Paris, Sorbonne University, Paris, France., Connors JM; Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Khorana AA; Taussig Cancer Institute and Case Comprehensive Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Kakkar A; Thrombosis Research Institute, London, UK; Faculty of Medical Sciences, University College London, London, UK., Ay C; Clinical Division of Hematology and Hemostaseology, Department of Medicine, Medical University of Vienna, Vienna, Austria., Muñoz A; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain., Brenner B; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel., Prata PH; Hematology-Transplantation Department, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Nord-Université de Paris, Paris, France., Brilhante D; Francisco Gentil Portuguese Institute of Oncology, Lisbon Center, Lisbon, Portugal., Antic D; Clinic for Hematology, Clinical Center Serbia, University of Belgrade, Belgrade, Serbia., Casais P; Instituto de Investigaciones en Salud Pública, Universidad de Buenos, Buenos Aires, Argentina., Guillermo Esposito MC; Departamento Clínico de Medicina, Manuel Quintela Clinic Hospital, Montevideo, Uruguay., Ikezoe T; Department of Hematology, Fukushima Medical University, Fukushima, Japan., Abutalib SA; Cancer Treatment Centers of America, Chicago, IL, USA., Meillon-García LA; The ABC Medical Center, Mexico City, Mexico., Bounameaux H; Faculty of Medicine, University of Geneva, Geneva, Switzerland., Pabinger I; Clinical Division of Hematology and Hemostaseology, Department of Medicine, Medical University of Vienna, Vienna, Austria., Douketis J; Department of Medicine, McMaster University, Hamilton, ON, Canada.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2022 Jul; Vol. 23 (7), pp. e334-e347.

ASH, ABHH, ACHO, Grupo CAHT, Grupo  CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America.

Autor: Neumann I; Department of Internal Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile., Izcovich A; Hospital Alemán, Buenos Aires, Argentina., Aguilar R; Servicio de Hematología, Complejo Hospitalario Dr. Arnulfo Arias Madrid, Panama City, Panama., Basantes GL; Clínica Universitaria Colombia, Bogotá, Colombia., Casais P; Epidemiología Clínica y Evidencia, Instituto de Investigaciones en Salud Pública, Universidad de Buenos Aires, Buenos Aires, Argentina.; Centro de Hematología Pavlovsky, Buenos Aires, Argentina., Colorio CC; Fundación Favaloro, Buenos Aires, Argentina., Esposito MCG; Hospital de Clínicas Dr. Manuel Quintela, Montevideo, Uruguay., Lázaro PPG; Faculty of Medicine, Universidad Privada Antenor Orrego, Trujillo, Peru.; Hospital Especializado Víctor Lazarte Echegaray, Trujillo, Peru., Meillon-García LA; The ABC Medical Center, Mexico City, Mexico., Pereira J; Department of Hematology and Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile., Rezende SM; Department of Internal Medicine, Faculty of Medicine Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Serrano JC; Unidad Hematológica Especializada IPS, Cucuta, Colombia., Valle MLT; Caja Petrolera de Salud, La Paz, Bolivia., Vera F; School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom., Karzulovic L; Department of Pediatrics, Pontificia Universidad Católica de Chile, Santiago, Chile; and., Rada G; Department of Internal Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile., Schünemann H; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.

Publikováno v: Blood advances [Blood Adv] 2021 Aug 10; Vol. 5 (15), pp. 3032-3046.

In vivo effects of an inhibitor of nuclear factor-kappa B on thrombogenic properties of antiphospholipid antibodies.

Autor: Montiel-Manzano G; Division of Rheumatology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas 77555-1165, USA., Romay-Penabad Z, Papalardo de Martínez E, Meillon-García LA, García-Latorre E, Reyes-Maldonado E, Pierangeli SS

Publikováno v: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2007 Jun; Vol. 1108, pp. 540-53.